Hikma Gets FTC Nod For Custopharm Deal – But With Strings Attached

Acquisition Moves Closer To Completion, But Combining Firms Must Lose A Product

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.